Showing posts with label cannabis. Show all posts
Showing posts with label cannabis. Show all posts
Thursday, July 25, 2019
Tuesday, July 23, 2019
FDA warns company marketing unapproved cannabidiol products - FDA.gov
Read the full news release: FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety - Agency is expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD - FDA.gov
According to the news release:
"... the U.S. Food and Drug Administration announced that it has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases. ...
The FDA has previously sent warning letters to other companies illegally selling CBD products that claimed to prevent, diagnose, treat, or cure serious diseases, such as cancer. Some of these products were in further violation of the Federal Food, Drug and Cosmetic Act because they were marketed as dietary supplements or because they involved the addition of CBD to food."Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
------------------
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store
Tuesday, July 2, 2019
COULD CANNABIS COMBAT THE OPIOID CRISIS? MARIJUANA USERS SAY DRUG HELPED THEM STOP PRESCRIPTION MEDS - Newsweek
Read the full article: COULD CANNABIS COMBAT THE OPIOID CRISIS? MARIJUANA USERS SAY DRUG HELPED THEM STOP PRESCRIPTION MEDS - Newsweek
"Cannabis could be used instead of prescription and over-the-counter medications - including opioids - to treat pain and insomnia, researchers have found. The team also found that many people who took marijuana for pain had been able to stop taking opioids, potentially suggesting it could lower the use of these pain relievers."Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store
Wednesday, June 12, 2019
F.D.A. tackling C.B.D. in food - Food Business News
Read the full article: F.D.A. tackling C.B.D. in food - Food Business News
"Stakeholders in the manufacture, distribution, use and regulation of products containing cannabis or cannabis-derived compounds, such as cannabidiol (C.B.D.), had their say before a panel of Food and Drug Administration officials during a daylong public hearing held May 31 at the agency’s White Oak Campus in Silver Spring, Md. More than 400 individuals and associations applied to address the panel; more than 100 were able to do so."
According to "Amy Abernethy, Ph.D., the F.D.A.’s deputy commissioner ... “Key questions about product safety need to be addressed. Data are needed to determine the safety thresholds for C.B.D … There are both positive supporters of cannabis and cannabis-derived products including C.B.D. and also concerned citizens worried that widely available products can be harmful.”"
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
------------------------
 |
| FDA cGMP QSR GMP Training Courses by SkillsPlus International Inc. |
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store
Thursday, February 28, 2019
FDA plans first public hearings on legalizing CBD foods in April - CNBC
Read the full article: FDA plans first public hearings on legalizing CBD foods in April - CNBC
"The Food and Drug Administration will hold its first public hearings on CBD in April as the agency weighs rules allowing companies to add the popular cannabis-based compound to food, Commissioner Scott Gottlieb said Wednesday.
"We're deeply focused on this. We have taken on other hard challenges before," Gottlieb told the House Appropriations Committee on Wednesday. "You have my commitment I'm focused on this one.""
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store
Monday, June 23, 2014
Marijuana Considered for Looser Restrictions by U.S. FDA - Bloomberg
Read the full article: Marijuana Considered for Looser Restrictions by U.S. FDA - Bloomberg:
"U.S. regulators are studying whether restrictions on marijuana should be eased, a step toward decriminalizing the drug at the federal level.
The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug, said Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, at a congressional hearing."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
"U.S. regulators are studying whether restrictions on marijuana should be eased, a step toward decriminalizing the drug at the federal level.
The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug, said Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, at a congressional hearing."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
Saturday, February 20, 2010
Univ of CA CMCR - Evidence Cannabis Is A Promising Treatment
Image via Wikipedia"The CMCR has successfully conducted the first clinical trials of smoked cannabis in the United States in more than 20 years. As a result of this program of systematic research, we now have reasonable evidence that cannabis is a promising treatment in selected pain syndromes caused by injury or diseases of the nervous system, and possibly for painful muscle spasticity due to multiple sclerosis."Learn More:
Understanding Marijuana: A New Look at the Scientific Evidence
Return Home: http://drughealth.blogspot.com/
The Health, Drug, Prescription, and GMP Supersite Gift Store
Saturday, June 20, 2009
Marijuana Can Damage DNA and Cause Cancer
Updated July 6, 2022
The original link broke.
You can still read about the same topic here:
--- the original post follows below ---
Return Home: http://drughealth.blogspot.com/
Subscribe to:
Posts (Atom)
Posts
